David W. Griggs

Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy

Amir Abdollahi, David W. Griggs, Heike Zieher et al. · Clinical Cancer Research · 2005 · 204 citations · Full text

Cancer Biology, Tumor Biology, Radiation Medicine +16

A small molecule antagonist of the α v β3 integrin suppresses MDA-MB-435 skeletal metastasis

John F. Harms, Danny R. Welch, Rajeev S. Samant et al. · Clinical & Experimental Metastasis · 2004 · 111 citations

VCC-1, a novel chemokine, promotes tumor growth

Edward J. Weinstein, Richard Head, David W. Griggs et al. · Biochemical and Biophysical Research Communications · 2006 · 81 citations

Medicine, Tumor Growth, Cancer Biology +4

Characteristics of Cation Binding to the I Domains of LFA-1 and MAC-1

David W. Griggs, Christina Schmidt, Christopher P. Carron · Journal of Biological Chemistry · 1998 · 23 citations · Full text

IDL-2965: A Selective, highly-potent, oral Integrin antagonist for IPF

Karl Kossen, Caralee Schaefer, Sharlene Lim et al. · 2019 · 10 citations

Antifibrotic Therapy, Inflammatory Lung Disease, Immunology +19